Search Results - "Willis, Kerry"

GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration by Levey, Andrew S., MD, Inker, Lesley A., MD, MS, Matsushita, Kunihiro, MD, PhD, Greene, Tom, PhD, Willis, Kerry, PhD, Lewis, Edmund, MD, de Zeeuw, Dick, MD, PhD, Cheung, Alfred K., MD, Coresh, Josef, MD, PhD

“…The US Food and Drug Administration currently accepts halving of glomerular filtration rate (GFR), assessed as doubling of serum creatinine level, as a…”
Get full text

Confluence of Epidemics of Hepatitis C, Diabetes, Obesity, and Chronic Kidney Disease in the United States Population by Lazo, Mariana, MD, PhD, ScM, Nwankwo, Chizoba, PhD, MPH, MS, Daya, Natalie R., MHS, Thomas, David L., MD, MPH, Mehta, Shruti H., PhD, Juraschek, Stephen, MD, PhD, Willis, Kerry, PhD, Selvin, Elizabeth, PhD, MPH

“…Background & Aims Obesity, kidney disease, and diabetes are common conditions that can affect outcomes of patients with chronic hepatitis C. We aimed to…”
Get full text

Potential Effects of Reclassifying CKD as a Coronary Heart Disease Risk Equivalent in the US Population by Foster, Meredith C., ScD, MPH, Rawlings, Andreea M., MS, Marrett, Elizabeth, MPH, Neff, David, DO, Grams, Morgan E., MD, MHS, Kasiske, Bertram L., MD, Willis, Kerry, PhD, Inker, Lesley A., MD, MS, Coresh, Josef, MD, PhD, Selvin, Elizabeth, PhD, MPH

“…Background Persons with chronic kidney disease (CKD) are at high risk for cardiovascular disease events, but are not classified as such in current US…”
Get full text

Challenges and Pitfalls of Operating a Rural Accountable Care Organization by Willis, Kerry A

Get full text

Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States by Foster, Meredith C., ScD, MPH, Rawlings, Andreea M., MS, Marrett, Elizabeth, MPH, Neff, David, DO, Willis, Kerry, PhD, Inker, Lesley A., MD, MS, Coresh, Josef, MD, PhD, Selvin, Elizabeth, PhD, MPH

“…Background Cardiovascular disease is a major concern in persons with chronic kidney disease (CKD). We assessed the current burden of cardiovascular risk…”
Get full text

Detection of Chemical Weapon Agents and Simulants Using Chemical Ionization Reaction Time-of-Flight Mass Spectrometry by Cordell, Rebecca L, Willis, Kerry A, Wyche, Kevin P, Blake, Robert S, Ellis, Andrew M, Monks, Paul S

“…Chemical ionization reaction time-of-flight mass spectrometry (CIR-TOF-MS) has been used for the analysis of prepared mixtures of chemical weapon agents (CWAs)…”
Get full text

Real-time multi-marker measurement of organic compounds in human breath: towards fingerprinting breath by White, Iain R, Willis, Kerry A, Whyte, Chris, Cordell, Rebecca, Blake, Robert S, Wardlaw, Andrew J, Rao, Satish, Grigg, Jonathan, Ellis, Andrew M, Monks, Paul S

“…The prospects for exploiting proton transfer reaction-time of flight-mass spectrometry (PTR-ToF-MS) in medical diagnostics are illustrated through a series of…”
Get more information

Differentiation of isobaric compounds using chemical ionization reaction mass spectrometry by Wyche, Kevin P., Blake, Robert S., Willis, Kerry A., Monks, Paul S., Ellis, Andrew M.

“…The technique of proton transfer reaction mass spectrometry (PTR‐MS) couples a proton transfer reagent, usually H3O+, with a drift tube and mass spectrometer…”
Get full text

Bronchiolitis: Advanced Practice Focus in the Emergency Department by Willis, Kerry C.

“…Willis discusses the impact of bronchiolitis on the patient, family and health care system, and assesses the familiarity of emergency nurses and advanced…”
Get full text

Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency by Levey, Andrew S., Gansevoort, Ron T., Coresh, Josef, Inker, Lesley A., Heerspink, Hiddo L., Grams, Morgan E., Greene, Tom, Tighiouart, Hocine, Matsushita, Kunihiro, Ballew, Shoshana H., Sang, Yingying, Vonesh, Edward, Ying, Jian, Manley, Tom, de Zeeuw, Dick, Eckardt, Kai-Uwe, Levin, Adeera, Perkovic, Vlado, Zhang, Luxia, Willis, Kerry

“…The US Food and Drug Administration (FDA) and European Medicines Agency (EMA) are currently willing to consider a 30% to 40% glomerular filtration rate (GFR)…”
Get full text

KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update by Daugirdas, John T., Depner, Thomas A., Inrig, Jula, Mehrotra, Rajnish, Rocco, Michael V., Suri, Rita S., Weiner, Daniel E., Greer, Nancy, Ishani, Areef, MacDonald, Roderick, Rutks, Indulis, Slinin, Yelena, Wilt, Timothy J., Rocco, Michael, Kramer, Holly, Choi, Michael J., Samaniego-Picota, Milagros, Scheel, Paul J., Willis, Kerry, Joseph, Jessica, Brereton, Laura

“…Abstract The National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative (KDOQI) has provided evidence-based guidelines for all stages of chronic…”
Get full text

Report of three case studies with olanzapine for chronic pain by Gorski, Eugene D, Willis, Kerry C

“…Olanzapine, an atypical antipsychotic, has broad spectrum psychotropic effects, affecting dopamine receptors 1, 2, and 3, 5-hydroxytryptamine 2A,…”
Get more information

Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by SCAI and NKF by Kandzari, David E., Townsend, Raymond R., Bakris, George, Basile, Jan, Bloch, Michael J., Cohen, Debbie L., East, Cara, Ferdinand, Keith C., Fisher, Naomi, Kirtane, Ajay, Lee, David P., Puckrein, Gary, Rader, Florian, Vassalotti, Joseph A., Weber, Michael A., Willis, Kerry, Secemsky, Eric

Get full text

Clinical Trial Considerations in Developing Treatments for Early Stages of Common, Chronic Kidney Diseases: A Scientific Workshop Cosponsored by the National Kidney Foundation and the US Food and Drug Administration by Inker, Lesley A., Grams, Morgan E., Guðmundsdóttir, Hrefna, McEwan, Phil, Friedman, Robert, Thompson, Aliza, Weiner, Daniel E., Willis, Kerry, Heerspink, Hiddo J.L., Little, Dustin, Jha, Vivek, West, Melissa, Levey, Andrew S., Walsh, Michael, Mottl, Amy K., Tangri, Navdeep, Madero, Magdalena, Patel, Uptal D., Gillespie, Barbara S., Crews, Deidra C., Levin, Adeera

“…In the past decade, advances in the validation of surrogate end points for chronic kidney disease (CKD) progression have heightened interest in evaluating…”
Get full text

A National Registry for People With All Stages of Kidney Disease: The National Kidney Foundation (NKF) Patient Network by Inker, Lesley A., Ferrè, Silvia, Baliker, Mary, Barr, Anne, Bonebrake, Lisa, Chang, Alexander R., Chaudhari, Juhi, Cooper, Kerry, Diamantidis, Clarissa J., Forfang, Derek, Gillespie, Barbara, Gregoriou, Petros, Gwadry-Sridhar, Femida, Ladin, Keren, Maxwell, Cari, Mitchell, Kristi R., Murphy, Kathleen P., Rakibuz-Zaman, Muhammad, Rocco, Michael V., Spry, Leslie A., Sharma, Amit, Tangri, Navdeep, Warfield, Curtis, Willis, Kerry

“…The National Kidney Foundation (NKF) launched the first national US kidney disease patient registry, the NKF Patient Network, that is open to patients…”
Get full text

Research Priorities for Kidney-Related Research—An Agenda to Advance Kidney Care: A Position Statement From the National Kidney Foundation

“…Despite the high prevalence and economic burden of chronic kidney disease (CKD) in the United States, federal funding for kidney-related research, prevention,…”
Get full text

National kidney foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification by LEVEY, Andrew S, CORESH, Josef, BALK, Ethan, KAUSZ, Annamaria T, LEVIN, Adeera, STEFFES, Michael W, HOGG, Ronald J, PERRONE, Ronald D, LAU, Joseph, EKNOYAN, Garabed

“…Chronic kidney disease is a worldwide public health problem with an increasing incidence and prevalence, poor outcomes, and high cost. Outcomes of chronic…”
Get full text

FP354PREVALENCE OF CHRONIC KIDNEY DISEASE BY ANTI HEPATITIS C VIRUS STATUS IN THE U.S. POPULATION by Lazo, Mariana, Daya, Natalie, Nwankwo, Chizoba, Willis, Kerry, Grams, Morgan, Selvin, Elizabeth

Get full text

Treating Early-Stage CKD With New Medication Therapies: Results of a CKD Patient Survey Informing the 2020 NKF-FDA Scientific Workshop on Clinical Trial Considerations for Developing Treatments for Early Stages of Common, Chronic Kidney DiseasesPlain-Language Summary by Kelli Collins Damron, Robert Friedman, Lesley A. Inker, Aliza Thompson, Morgan E. Grams, Hrefna Guðmundsdóttir, Kerry Willis, Tom Manley, Hiddo L. Heerspink, Daniel E. Weiner

“…Rationale & Objective: With a growing number of medications and therapies available to treat chronic kidney disease (CKD), risk-versus-benefit discussions are…”
Get full text

Treating Early-Stage CKD With New Medication Therapies: Results of a CKD Patient Survey Informing the 2020 NKF-FDA Scientific Workshop on Clinical Trial Considerations for Developing Treatments for Early Stages of Common, Chronic Kidney Diseases by Damron, Kelli Collins, Friedman, Robert, Inker, Lesley A., Thompson, Aliza, Grams, Morgan E., Guðmundsdóttir, Hrefna, Willis, Kerry, Manley, Tom, Heerspink, Hiddo L., Weiner, Daniel E.

“…With a growing number of medications and therapies available to treat chronic kidney disease (CKD), risk-versus-benefit discussions are increasingly critical…”
Get full text